AOD9604 is a modified analogue of the hGH C-terminal fragment (residues 177191 with N-terminal tyrosine addition and disulfide cyclisation), first synthesized in the 1990s by Metabolic Pharmaceuticals
The cost of the initial vial is $200. For batch/lot variance testing, all vials must be identical in every aspectincluding compound, label claim (strength in mg), manufacturer, cap color, and any other distinguishing featuresas the results are combined into a single Certificate of Analysis (COA)
The CAS number for AOD9604 is 386264-39-7, which uniquely identifies the compound for research and regulatory documentation
The corollary is that the temptation to increase the dose because nothing is happening yet is exactly backwards the protocol is built on consistency, and week 2 is not where you judge it
International Journal of Molecular Sciences, 20(10), 2383